These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1020068)

  • 21. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A thermodynamic equilibrium model for calcium salt urolithiasis: clinical application.
    Ashby R; Györy AZ
    Exp Nephrol; 1997; 5(3):246-52. PubMed ID: 9208285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
    Burdette DC; Thomas WC; Finlayson B
    J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazide diuretics for the treatment of children with idiopathic hypercalciuria and hematuria.
    Hymes LC; Warshaw BL
    J Urol; 1987 Nov; 138(5):1217-9. PubMed ID: 3669171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers.
    Peacock M
    Contrib Nephrol; 1982; 33():152-62. PubMed ID: 6288323
    [No Abstract]   [Full Text] [Related]  

  • 31. Seasonal variations in the composition of urine in relation to calcium stone-formation.
    Robertson WG; Peacock M; Marshall RW; Speed R; Nordin BE
    Clin Sci Mol Med; 1975 Dec; 49(6):597-602. PubMed ID: 1172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects in the treatment of oxalate lithiasis (author's transl)].
    Hautmann R; Hering FJ; Terhorst B; Lutzeyer W
    Urologe A; 1976 Jul; 15(4):148-52. PubMed ID: 960323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dietary and drug treatments of calcium nephrolithiasis (author's transl)].
    Mirouze J; Monnier L; Granier MP; Borderies A; Gauthier N
    Sem Hop; 1979 Jan 8-15; 55(1-2):7-13. PubMed ID: 34218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary calcium excretion in treated and untreated essential hypertension.
    Quereda C; Orte L; Sabater J; Navarro-Antolin J; Villafruela JJ; Ortuño J
    J Am Soc Nephrol; 1996 Jul; 7(7):1058-65. PubMed ID: 8829122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do indomethacin, thiazide, pyridoxine or allopurinol prevent calcium oxalate stones?
    Reis-Santos JM; Guimarães P; Correia R; Ferreira AM
    Contrib Nephrol; 1987; 58():176-80. PubMed ID: 3691121
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of nephrolithiasis].
    Tschöpe W; Ritz E
    Dtsch Med Wochenschr; 1985 Mar; 110(10):385-8. PubMed ID: 3971867
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic measures in recurrent calcium oxalate nephrolithiasis].
    Tschöpe W; Schmidt-Gayk H; Ritz E
    Schweiz Rundsch Med Prax; 1978 Sep; 67(38):1385-8. PubMed ID: 211499
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nephrolithiasis in hypercalciuria and hyperparathyroidism].
    Rapado A; de la Calle H; Castrillo JM; Mancha A; Traba ML; Delatte LC
    MMW Munch Med Wochenschr; 1976 Jun; 118(25):799-810. PubMed ID: 819807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.